1/18/2024 4:41:00 PM Biotech settlement agreements – a competition law checklist By Sophie Lawrance Sean-Paul Brankin This article is part of our Biotech Review of the Year - Issue 11 publication Introduction The European Commission (EC) published its...
1/18/2024 4:41:00 PM Strategic considerations for partnering with CDMOs for cell and gene therapies By Claire Smith Erik Müürsepp This article is part of our Biotech Review of the Year - Issue 11 publication The biopharmaceutical landscape is undergoing a steady but...
1/18/2024 4:40:00 PM Royalty monetisation – why some biotechs are turning to royalty aggregators to help unlock the future value of their out-licensed technology By Marek Petecki Ellen Lambrix This article is part of our Biotech Review of the Year - Issue 11 publication Ellen Lambrix and Marek Petecki in conversation with Brad...
1/18/2024 4:39:00 PM The UK Government’s Autumn 2023 Statement – support for life sciences By Julia Cockroft Nick Cross This article is part of our Biotech Review of the Year - Issue 11 publication The UK Government has announced significant investment...